Ads
related to: Pharmaceutical Drug Companies and Biotech Companies- Biotech Insights
Biotech bolsters the market but
tailwinds for services and HCIT.
- Biotech Balancing Act
Biotech juggles innovation,
competition, policy, and funding.
- Raising Capital
A new playbook for a new era
in biotech.
- About Us
RBC's History, Culture & Values
Learn More
- ECM: Robust End To Year
The rise of creative deal
structures in biotech.
- Healthcare Transformation
Disruptive forces in healthcare and
why HCIT is set to bounce back.
- Biotech Insights
Search results
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate | The Motley Fool
The Motley Fool· 2 days agoInvestors interested in the pharmaceutical industry are currently excited about the anti-obesity...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors
Digital Journal· 1 day agoHarnessing both global expertise and cutting-edge technology , G&L is expertly positioned to support the pharmaceutical, biopharmaceutical and biotechnology industry as it ...
Stocks making the biggest moves midday: GameStop, Paramount, Spotify, Krispy Kreme and more
CNBC· 2 days agoCheck out the companies making headlines in midday trading: GameStop — The meme stock jumped more...
Study Raises Concerns About Rising Cost of Diabetes Meds
Medscape· 5 days agoDriven by payments for diabetes treatments — especially insulin — prescription drugs for metabolic...
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 2 days agoShares of Structure Therapeutics jumped more than 45% Monday after a new clinical study boosted...
Space tech company breaks ground on local research and development facility (RENDERINGS) -...
The Business Journals· 4 days agoRedwire's facility, expected to bring about two dozen jobs, will work to meet growing demand for...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 3 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
Doctor’s Sons Turn Billionaires as Saudi IPOs Mint New Fortunes
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Saudi Arabia has long churned out fortunes built on oil and the business surrounding...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 7 days agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Ad
related to: Pharmaceutical Drug Companies and Biotech Companies